Not the same thing: metastatic PTCs have a different background than ATCs

Not the same thing: metastatic PTCs have a different background than ATCs

Anaplastic thyroid cancer (ATC) is a rare but highly aggressive form of thyroid cancer. By contrast, differentiated papillary thyroid cancer (PTC) only rarely behave aggressively and develop distant metastasis. Whether distantly metastatic PTC (DM-PTC) and ATC share a common genetic background is st...

Full description

Bibliographic Details
Main Authors:	Dario de Biase, Federica Torricelli, Moira Ragazzi, Benedetta Donati, Elisabetta Kuhn, Michela Visani, Giorgia Acquaviva, Annalisa Pession, Giovanni Tallini, Simonetta Piana, Alessia Ciarrocchi
Format:	Article
Language:	English
Published:	Bioscientifica 2018-11-01
Series:	Endocrine Connections
Subjects:	highly aggressive thyroid cancer genetic profile TERT promoter mutations anaplastic thyroid cancer papillary thyroid cancer MED12 mutations
Online Access:	https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0386.xml

Similar Items

Editorial: The role of genetic alterations in thyroid carcinoma
by: Joachim Feldkamp
Published: (2022-08-01)

Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance
by: Xiaotian Yuan, et al.
Published: (2022-11-01)

TERT promoter mutations in thyroid cancer
by: Michiko Matsuse, et al.
Published: (2023-11-01)

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
by: Noha Mukhtar, et al.
Published: (2023-10-01)

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
by: Martina Tavarelli, et al.
Published: (2017-10-01)

Validation of two predictive models for survival in anaplastic thyroid cancer (ATC)
by: Lukas Käsmann, et al.
Published: (2024-11-01)

Anaplastic Thyroid Cancer: Experience of the Philippine General Hospital
by: Tom Edward Lo, et al.
Published: (2015-06-01)

Anaplastic Carcinoma Thyroid in a Young Child – an Extremely Rare Occurrence
by: Suresh Chandra Sharma, et al.
Published: (2019-01-01)

Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions
by: Ashleigh Porter, et al.
Published: (2021-01-01)

Thyroid carcinoma metastases to central nervous system and vertebrae
by: Bette Kleinschmidt-DeMasters, et al.
Published: (2022-08-01)

Progress of Targeted Therapy for Anaplastic Thyroid Cancer
by: Detao YIN, et al.
Published: (2024-08-01)

A case report of simultaneous medullary and papillary carcinoma of thyroid
by: Ziaolhagh Reza, et al.
Published: (2021-04-01)

Mutational profiling of Chinese patients with thyroid cancer
by: Yaying Du, et al.
Published: (2023-07-01)

Rare clinical observation of pronounced response to immunotherapy in a patient with anaplastic thyroid cancer
by: D. M. Vontlaya, et al.
Published: (2024-06-01)

Thyroid Mutations and Implications for Clinical Treatment
by: Emily S. Zhang, et al.
Published: (2024-12-01)

Rare and novel GNAS gene mutations in Chinese patients with thyroid cancer
by: Zhuo Wang, et al.
Published: (2021-06-01)

Anaplastic carcinoma of the thyroid in a 12-year old girl
by: Rodrigo Mon, et al.
Published: (2015-09-01)

Long Non-Coding RNAs as Determinants of Thyroid Cancer Phenotypes: Investigating Differential Gene Expression Patterns and Novel Biomarker Discovery
by: Nicole R. DeSouza, et al.
Published: (2024-04-01)

Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review
by: Poupak Fallahi, et al.
Published: (2023-11-01)

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
by: Danielle Pessôa-Pereira, et al.
Published: (2019-03-01)

Kinase inhibitors in thyroid cancers
by: Vineeth Sukrithan, et al.
Published: (2024-02-01)

Development of animal models to study aggressive thyroid cancers
by: Shovan Dutta, et al.
Published: (2025-02-01)

Introduction and expression of PIK3CA E545K in a papillary thyroid cancer BRAF V600E cell line leads to a dedifferentiated aggressive phenotype
by: Nicole Pinto, et al.
Published: (2022-02-01)

Knowledge mapping of anaplastic thyroid cancer treatments: a bibliometric analysis (2000-2023)
by: Shiqiang Liu, et al.
Published: (2024-02-01)

New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
by: Laetitia Gheysen, et al.
Published: (2021-05-01)

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
by: Priyanka C. Iyer, et al.
Published: (2018-07-01)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
by: Simona Censi, et al.
Published: (2017-10-01)

Anaplastic thyroid cancer. Is there a light at the end of the tunnel?
by: A. L. Pylev, et al.
Published: (2020-04-01)

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
by: Daniele Barbaro, et al.
Published: (2024-07-01)

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
by: Mila Gugnoni, et al.
Published: (2022-03-01)

Efficacy and Safety of Pazopanib in the Treatment of Thyroid Cancer: A Systematic Review
by: Alexandra Laura Mederle, et al.
Published: (2024-12-01)

Anaplastic thyroid cancer with life-threatening symptoms in an older female - a case report
by: Wojciech Pawęska, et al.
Published: (2023-08-01)

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer
by: Gongxun Tan, et al.
Published: (2024-10-01)

Editorial: Molecular Characterization of Thyroid Lesions in the Era of “Next-Generation” Techniques
by: Claudio Bellevicine, et al.
Published: (2022-06-01)

New opportunities for preoperative diagnosis of anaplastic thyroid cancer
by: S. A. Lukyanov, et al.
Published: (2021-04-01)

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma
by: Enrique Grande, et al.
Published: (2013-01-01)

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
by: Federica Panebianco, et al.
Published: (2019-10-01)

MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer
by: Jun Zhou, et al.
Published: (2022-11-01)

Thyroid cancer in Ecuador: A genetic variants review and a cross-sectional population-based analysis before and after COVID-19 pandemic
by: Elius Paz-Cruz, et al.
Published: (2024-01-01)

Low Prevalence of Somatic Promoter Mutations in Classic Papillary Thyroid Carcinoma
by: Min Ji Jeon, et al.
Published: (2016-03-01)